Pascal Ringwald spends much of his time researching Plasmodium falciparum, Malaria, Drug resistance, Artemisinin and Internal medicine. The Plasmodium falciparum study combines topics in areas such as Genetics and Multiple drug resistance. The concepts of his Malaria study are interwoven with issues in Tropical medicine and Surgery.
His Artemisinin research is multidisciplinary, incorporating elements of Nonsynonymous substitution, Combination therapy, Public health and Virology. His work investigates the relationship between Virology and topics such as Allele that intersect with problems in Molecular marker. The study incorporates disciplines such as Mefloquine, Sulfadoxine and Pharmacology in addition to Internal medicine.
The scientist’s investigation covers issues in Malaria, Plasmodium falciparum, Drug resistance, Artemisinin and Virology. His Malaria research includes elements of Internal medicine and Combination therapy. His Plasmodium falciparum research is multidisciplinary, incorporating perspectives in Genetics, Chloroquine and Pharmacology.
His Drug resistance research includes themes of Public health, Drug, Parasitology and Haplotype. His research is interdisciplinary, bridging the disciplines of Mutation and Artemisinin. His research in Virology intersects with topics in Pyrimethamine, Cycloguanil, Point mutation and Molecular epidemiology, Genotype.
Pascal Ringwald mainly investigates Plasmodium falciparum, Malaria, Artemisinin, Drug resistance and Internal medicine. The various areas that Pascal Ringwald examines in his Plasmodium falciparum study include Mutant and Virology. Pascal Ringwald combines subjects such as Haplotype, Genotype, Traditional medicine and Copy-number variation with his study of Malaria.
His studies examine the connections between Artemisinin and genetics, as well as such issues in Mutation, with regards to Lineage. Pascal Ringwald has included themes like Single-nucleotide polymorphism and Public health in his Drug resistance study. His Internal medicine study combines topics in areas such as Parasitemia, Artesunate and Primaquine.
His primary scientific interests are in Plasmodium falciparum, Artemisinin, Malaria, Drug resistance and Genetics. His Plasmodium falciparum research integrates issues from Lineage, Parasitology, Mutation, Mutant and Single-nucleotide polymorphism. As part of the same scientific family, he usually focuses on Parasitology, concentrating on Tropical medicine and intersecting with Dihydroartemisinin/piperaquine and Artemether/lumefantrine.
His work deals with themes such as Internal medicine, Combination therapy, Prospective cohort study and Virology, which intersect with Artemisinin. His work carried out in the field of Internal medicine brings together such families of science as Artesunate, Pyronaridine and Primaquine. He studied Malaria and Genotype that intersect with Genomics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Artemisinin Resistance in Plasmodium falciparum Malaria
Arjen M. Dondorp;François Nosten;Poravuth Yi;Debashish Das.
The New England Journal of Medicine (2009)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frédéric Ariey;Benoit Witkowski;Chanaki Amaratunga;Johann Beghain.
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data
EA Ashley;F Aweeka;KI Barnes;Q Bassat.
BMC Medicine (2015)
Genetic architecture of artemisinin-resistant Plasmodium falciparum.
O Miotto;R Amato;E A Ashley;B MacInnis.
Nature Genetics (2015)
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
Olivo Miotto;Jacob Almagro-Garcia;Jacob Almagro-Garcia;Jacob Almagro-Garcia;Magnus Manske;Bronwyn MacInnis.
Nature Genetics (2013)
A Worldwide Map of Plasmodium Falciparum K13-Propeller Polymorphisms
Didier Ménard;Nimol Khim;Johann Beghain;Ayola A. Adegnika;Ayola A. Adegnika.
The New England Journal of Medicine (2016)
Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia
Shannon Takala-Harrison;Christopher G. Jacob;Cesar Arze;Michael P. Cummings.
The Journal of Infectious Diseases (2015)
A research agenda for malaria eradication: drugs.
PL Alonso;Q Bassat.
PLOS Medicine (2011)
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study
Benoit Witkowski;Valentine Duru;Nimol Khim;Leila S Ross.
Lancet Infectious Diseases (2017)
Systematic review of amodiaquine treatment in uncomplicated malaria
P Olliaro;C Nevill;J LeBras;P Ringwald.
The Lancet (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: